ERBB2 and breast carcinoma: Median time from primary breast cancer diagnosis to LM development was 52.8 months (range, 0.6‐188.2) for HR+/HER2+ breast cancer subtype and 43.2 months (range, 9.1‐244.4) for HR−/HER2+ breast cancer subtype (P = .852).